Laura A. Brege
|Age||Total Calculated Compensation||This person is connected to 47 board members in 7 different organizations across 11 different industries.|
See Board Relationships
Ms. Laura A. Brege served as the Chief Executive Officer and President of Nodality, Inc., from September 24, 2012 to July 2015. Ms. Brege has more than five decades of biotechnology and pharmaceutical industry experience with both privately-held and publicly-traded companies. Prior to joining Nodality in 2012, she served as an Executive Vice President of Corporate Affairs at Onyx Pharmaceuticals, Inc from January 2011 to December 31, 2011 and served as its Executive ...
170 Harbor WayPhone: 650-827-8000
South San Francisco, California 94080
Board Members Memberships*
Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Independent Director and Member of Audit Committee
The University of Chicago
Annual Compensation*There is no Annual Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|James E. Brown D.V.M.||Co-Founder, Chief Executive Officer, President and Director|
|Rajat Rai||Chief Executive Officer|
|Lars Marcher||Chief Executive Officer, President and Member of Executive Board|
|A. J. Kazimi MBA||Founder, Chairman, Chief Executive Officer and President|
Cumberland Pharmaceuticals Inc.
|Robert E. Abernathy||Chairman, Chief Executive Officer, President and Member of Executive Committee|
Halyard Health, Inc.
|$837.4K||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.